At 13-month #YesCCT evaluation post-LAA closure, the majority of 45-day LAA patency persists, whereas new onset LAA patency is rare. https://t.co/1BjXcsrMK5 #cvLAAoccluder #JACCIMG #cvImaging @vlgmrc

Dr. @adnanalkhouli et al. observe similar technical success (97.8% vs 97.4%), complications & global cost in routine use of left atrial intracardiac #cvEcho compared to transesophageal #EchoFirst to guide left atrial occlusion. https://t.co/5MT9Bznd77 #JACCCEP #cvLAAoccluder

#JACCCaseReports: An 86 y/o female with #AFib and recurrent GI bleeding ➡️ LA appendage closure device inserted ➡️ hypoxia ➡️ TEE: Iatrogenic ASD+R to L shunt ➡️ emergent transcatheter ASD closure. https://t.co/hKxKMWeGy2 #cvLAAoccluder #CardioTwitter #MedTwitter

New in #JACCCaseReports: First report on persistence and distortion of electrical left atrial appendage activity, five years after endovascular occlusion with a Watchman device. https://t.co/hs7bWBi7iV #cvLAAoccluder

LAA electrical isolation is associated with a significant risk of #stroke that can be effectively reduced by optimal uninterrupted OAC or #cvLAAoccluder devices. https://t.co/akXR9NJqbx #JACC

Anchoring atrial cuffs of dedicated transcatheter mitral valve bioprostheses can interfere with transcatheter #cvLAAoccluder. @MHIValveDoc demonstrated this during Watchman device implantation in a patient who had prior #TMVR w/ Tendyne. Learn w/ #JACCINT: https://t.co/7kwjOXVogf

What is the feasibility and safety of direct-current #cardioversion in patients with the Watchman device? Learn more in this week's #JACC. https://t.co/v26rlk8Vjk #cvLAAoccluder

New #JACCINT study finds atrial appendage (LAA) leak occlusion with endovascular coils in incomplete LAA closure appears to be a safe, effective, and promising approach! https://t.co/Xl8PcqM5Kq #LAAClosure #cvLAAoccluder @LuigiDiBiaseMD

State-of-the-art review summarizes current state of postprocedural antithrombotic therapy (#DAPT, #cvCoag, #NOAC) & 🩸risk assessment following #TAVR, #TEER, and #cvLAAoccluder. https://t.co/to6s82JJb4 #JACCAsia #ACCIntl @Yusukeewatanabe

#LAAO in patients with a thrombotic event on oral anticoagulation therapy (OAT) demonstrated comparable stroke rates to the OAT contraindicated population in EWOLUTION. https://t.co/VNZBcX7Xx6 #JACCINT #cvCoag #AFib #cvLAAoccluder

LAA closure in #AFib patients: Lower #stroke risk, but at what cost? https://t.co/SiR6M2BF42 #JACC #cvLAAoccluder @fauchierlaurent

In its first three years, the #NCDR LAAO Registry enrolled >38k patients w/ the Watchman #cvLAAoccluder. Patients had lower in-hospital adverse event rates, compared to those in pivotal trials. Explore the data first presented at #ACC20/#WCCardio in #JACC. https://t.co/ARtGiVWBJz

Wondering how to differentiate LAA sludge from thrombus prior to #LAAO via #cvEcho? Check out the approach and outcomes of #cvLAAoccluder in patients with LAA sludge in #JACCCEP: https://t.co/cpII2fQbKX #CardioTwitter #EPeeps @DrSGoyal_EP

Direct current #cardioversion feasible in high-risk #AFib patients w/ a #cvLAAoccluder device without need for oral #cvCoag if pre-procedural TEE shows good device position, no device-related thrombus and peri-device leak ≤5 mm. https://t.co/muzFN8rT94 #JACC

New #JACC study reports on the long-term outcomes of #cvLAAoccluder devices for #stroke prevention in patients with nonvalvular #AFib using data from two @FDADeviceInfo mandated registries. https://t.co/YStPjbcOgP

Can endoscopic evaluation assess endothelialization of the Watchman device? Doctors from Toho University Ohashi Medical Center present their experience with a 55-yr-old patient with dilated #cardiomyopathy, #AFib and #heartfailure. https://t.co/EZ92RAm1TA #JACCINT #cvLAAoccluder

In this #JACCBTS article, Dr. Fengyuan Yu, et al. demonstrate feasibility and safety of a novel LAA occlusion and pulsed field electrical isolation device in canines. https://t.co/jBi4xMjJ27 #AFib #PFA #LAAO #cvLAAoccluder

Are you regularly using #cvLAAoccluder devices for your patients who cannot tolerate long-term #cvCoag? New #JACC study suggests they’re quite safe and effective. What do you think? https://t.co/YStPjbcOgP

Cutting-Edge Tech: First-in-human experience of steerable, deflectable sheath use in #cvLAAoccluder implantation: https://t.co/RCc5v9edAA #JACCAsia #LAAO #ACCIntl #CardioTwitter

#cvLAAoccluder reduced the risk of ischemic #stroke compared to the predicted rate, with a greater magnitude among patients at high thromboembolic risk without increasing the risk for bleeding. https://t.co/I9V5Y9Ld84 #JACCIMG @gianpiero_d